Barriers and Facilitators to Vaccine Equity Amidst the COVID-19 Vaccine Rollout in the United States

Rachael Piltch-Loeb, Josefina Nuñez Sahr, La Ron E. Nelson, David Vlahov, Robyn R. Gershon

Research output: Contribution to journalArticlepeer-review

Abstract

State and local health departments were responsible for ensuring equitable distribution of the COVID-19 vaccine. This qualitative study aimed to identify the challenges, strategies, disappointments, and successes in achieving equity for hard-to-reach and at-risk populations. Using a purposive sampling strategy, 16 individuals affiliated with health departments across nine states, each holding leadership roles in vaccine distribution, were interviewed between late 2021 and mid-2022. The key factors promoting vaccine equity included (1) inviting community members to serve on vaccine advisory groups to participate in decision-making; (2) utilizing pre-existing community relationships and spaces to facilitate the planning and distribution of the vaccine; and (3) establishing and building upon community outreach to support accessibility and uptake of the vaccine. The barriers included (1) a lack of clarity on vaccine prioritization criteria; (2) language/communication access; and (3) the initial focus on mass vaccination sites for vaccine delivery. The stakeholders also highlighted potential facilitators for increasing equity in future vaccine rollouts. Overall, community engagement emerged as a critical factor in ensuring equity during disaster response efforts.

Original languageEnglish (US)
Article number1588
JournalInternational journal of environmental research and public health
Volume21
Issue number12
DOIs
StatePublished - Dec 2024

Keywords

  • COVID-19
  • community engagement
  • healthcare access
  • public health
  • qualitative study
  • vaccine equity

ASJC Scopus subject areas

  • Pollution
  • Public Health, Environmental and Occupational Health
  • Health, Toxicology and Mutagenesis

Fingerprint

Dive into the research topics of 'Barriers and Facilitators to Vaccine Equity Amidst the COVID-19 Vaccine Rollout in the United States'. Together they form a unique fingerprint.

Cite this